Innovation ARDEAPHARMA, a.s. (Q9941): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 15:23, 28 October 2020

Project Q9941 in Czech Republic
Language Label Description Also known as
English
Innovation ARDEAPHARMA, a.s.
Project Q9941 in Czech Republic

    Statements

    0 references
    6,300,000.0 Czech koruna
    0 references
    252,000.0 Euro
    10 January 2020
    0 references
    14,000,000.0 Czech koruna
    0 references
    560,000.0 Euro
    10 January 2020
    0 references
    45 percent
    0 references
    21 September 2015
    0 references
    19 September 2018
    0 references
    20 September 2018
    0 references
    ARDEAPHARMA, a.s.
    0 references
    0 references

    49°5'42.72"N, 14°33'56.70"E
    0 references
    37363
    0 references
    ARDEAPHARMA, a.s. je farmaceutická společnost v kategorii malý podnik, která má české vlastníky a jako jediná svého druhu působí na českém trhu vedle nadnárodních farmaceutických korporací. V téměř 20-leté historii vykazuje kladné hospodaření a dosud nečerpala finanční podporu z fondů EU. Projekt je zaměřen na inovaci výrobků a související inovaci výrobního a kontrolního procesu společnosti, s cílem posílit konkurenceschopnost jak na domácím trhu, tak i směrem k zahraničí. a. (Czech)
    0 references
    ARDEAPHARMA, a.s. is a pharmaceutical company in the category of small enterprise, which has Czech owners and is the only one of its kind operating on the Czech market alongside multinational pharmaceutical corporations. In almost 20-year history, it has shown a positive economy and has not yet received financial support from EU funds. The project is focused on innovation of products and related innovation of the company’s production and control process in order to strengthen competitiveness both on the domestic market and towards abroad. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_014/0004450
    0 references